Previous studies reported that exopolysaccharides from microorganisms alleviated symptoms of colon cancer via modulating gut microbiota and metabolites, enhancing intestinal barrier function, inhibiting NF-κB signaling pathway, and reducing tumor burden [7,14,15,16,17]. The gene discussed is NFKB1; the disease is malignant colon neoplasm.